This article was published online on May 11, 2009. An error was subsequently identified. This notice is included in the online and print versions to indicate that both have been corrected May 29, 2009.
Adalimumab safety in global clinical trials of patients with Crohn's disease†
Version of Record online: 11 MAY 2009
Copyright © 2009 Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 15, Issue 9, pages 1308–1319, September 2009
How to Cite
Colombel, J.-F., Sandborn, W. J., Panaccione, R., Robinson, A. M., Lau, W., Li, J. and Cardoso, A. T. (2009), Adalimumab safety in global clinical trials of patients with Crohn's disease. Inflamm Bowel Dis, 15: 1308–1319. doi: 10.1002/ibd.20956
- Issue online: 19 AUG 2009
- Version of Record online: 11 MAY 2009
- Manuscript Accepted: 17 MAR 2009
- Manuscript Received: 16 MAR 2009
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!